These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14058167)

  • 1. ORAL I-131 TRIOLEIN TOLERANCE CURVES IN NORMAL, ATHEROSCLEROTIC AND HYPERLIPAEMIC SUBJECTS.
    PRIOR IA; ARMSTRONG WE; CARR AH
    Australas Ann Med; 1963 Aug; 12():208-15. PubMed ID: 14058167
    [No Abstract]   [Full Text] [Related]  

  • 2. [ON THE EFFECT OF SERUM LIPID CONCENTRATION ON THE I-131-TRIOLEIN TOLERANCE TEST].
    JUNG GF; JAHNKE K; BREITBACH A
    Z Gesamte Exp Med; 1963 Dec; 137():554-60. PubMed ID: 14124496
    [No Abstract]   [Full Text] [Related]  

  • 3. COMPARISON OF THE DIAGNOSTIC VALUE OF A MODIFIED 131-I TRIOLEIN TEST WITH THAT OF THE TESTS FOR TOTAL SERUM LIPID, CHOLESTEROL AND BETA-LIPOPROTEIN IN CORONARY HEART DISEASE.
    ERDELYI G; KELLER L
    J Atheroscler Res; 1965; 5(2):255-8. PubMed ID: 14273076
    [No Abstract]   [Full Text] [Related]  

  • 4. [ON THE INCIDENCE OF LIPEMIA CLEARING INSUFFICIENCY IN VARIOUS DISEASES].
    SCHOEN H; LOCHNER L
    Dtsch Med J; 1964 Jan; 15():50-6. PubMed ID: 14139468
    [No Abstract]   [Full Text] [Related]  

  • 5. [STUDIES ON THE LIPID METABOLISM WITH THE USE OF I-131 LABELED FATS IN CORONARY ARTERIOSCLEROSIS PATIENTS].
    PARAMONOVA EG; KARATAEV KM
    Ter Arkh; 1964 May; 36():8-13. PubMed ID: 14218804
    [No Abstract]   [Full Text] [Related]  

  • 6. ATHEROGENIC INDICES. A REVIEW AND EVALUATION.
    STRAUS R; WURM M; KOSITCHEK RJ
    Am J Clin Pathol; 1964 Apr; 41():352-65. PubMed ID: 14159208
    [No Abstract]   [Full Text] [Related]  

  • 7. THE EFFECTS OF ATROMID ON SERUM CHOLESTEROL, SERUM TRIGLYCERIDES, AND RADIOACTIVE FAT TOLERANCE IN PATIENTS WITH HYPERLIPIDEMIA. A PRELIMINARY REPORT.
    BERKOWITZ D
    J Atheroscler Res; 1963; 3():538-41. PubMed ID: 14100895
    [No Abstract]   [Full Text] [Related]  

  • 8. [STUDIES ON THE INFLUENCING OF FAT CLEARANCE IN VIVO].
    SCHOEN H; NEUMANN J
    Dtsch Med J; 1964 Feb; 15():98-101. PubMed ID: 14153957
    [No Abstract]   [Full Text] [Related]  

  • 9. [STUDIES OF BLOOD RADIOACTIVITY IN ATHEROSCLEROSIS AFTER INGESTION OF TRIOLEIN LABELED WITH I-131].
    FRONESCU E; REBEDEA D; GHEORGHESCU B; BRASLA I
    Med Interna (Bucur); 1964 Nov; 16():1327-32. PubMed ID: 14244212
    [No Abstract]   [Full Text] [Related]  

  • 10. [FURTHER STUDIES ON HYPERLIPEMIC ATHEROSCLEROSIS].
    SCHOEN H; BERG G; SCHUERGER W
    Med Welt; 1964 Feb; 8():390-2. PubMed ID: 14136966
    [No Abstract]   [Full Text] [Related]  

  • 11. [BLOOD SERUM CHOLESTEROL AND TOTAL BLOOD LIPIDS IN 3324 EXAMINED SUBJECTS].
    RETSAGI G; KELLER L
    Orv Hetil; 1964 Nov; 105():2225-9. PubMed ID: 14232613
    [No Abstract]   [Full Text] [Related]  

  • 12. HEPARIN VERSUS ORAL ANTICOAGULANT THERAPY IN CORONARY ATHEROSCLEROSIS: REVIEW OF ADVANTAGES AND DISADVANTAGES.
    HUGHES ML; MORTENSEN F; SHOURIE L
    South Med J; 1964 Mar; 57():292-6. PubMed ID: 14128542
    [No Abstract]   [Full Text] [Related]  

  • 13. A PERSPECTIVE OF BIOLOGICAL AND OTHER FACTORS CONTRIBUTING TO CORONARY ARTERIOSCLEROSIS.
    SHAFFER CF
    Med Times; 1964 Jul; 92():664-77. PubMed ID: 14181736
    [No Abstract]   [Full Text] [Related]  

  • 14. ANTICOAGULANTS IN THE MANAGEMENT OF VARIOUS THROMBOEMBOLIC DISEASES.
    BRADFORD HA
    Angiology; 1964 Jan; 15():35-41. PubMed ID: 14104838
    [No Abstract]   [Full Text] [Related]  

  • 15. TRIOLEIN-I-131 TOLERANCE IN PATIENTS WITH CORONARY HEART DISEASE.
    CARRUTHERS BM; MCINTOSH HW
    Can Med Assoc J; 1964 May; 90(21):1213-4. PubMed ID: 14144541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STUDIES OF THE METABOLISM OF RADIOIODINATED HUMAN SERUM ALPHA LIPOPROTEIN IN NORMAL AND HYPERLIPIDEMIC SUBJECTS.
    FURMAN RH; SANBAR SS; ALAUPOVIC P; BRADFORD RH; HOWARD RP
    J Lab Clin Med; 1964 Feb; 63():193-204. PubMed ID: 14125106
    [No Abstract]   [Full Text] [Related]  

  • 17. [On determination of I-131-labelled triolein tolerance in diabetes mellitus and arteriosclerosis].
    JUNG GF; JAHNKE K; BURG H
    Z Gesamte Exp Med; 1963; 136():351-60. PubMed ID: 13958052
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of anticoagulant therapy on serum cholesterol levels.
    WELLS AO; HOLLOMAN JL; WROBLEWSKI F
    J Am Geriatr Soc; 1962 Oct; 10():885-8. PubMed ID: 13999871
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
    Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
    [No Abstract]   [Full Text] [Related]  

  • 20. Preparation of 131 I-labeled fat emulsions and distribution of the label in serum lipoproteins and lipid classes following intravenous infusion to normal and hyperlipemic subjects.
    Lakshminarayana G; O'Connell PW; Kruger FA; Hamwi GJ; Cornwell DG
    Am J Clin Nutr; 1972 May; 25(5):531-8. PubMed ID: 4336654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.